News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Rachel E. Eisenberg

Articles by Rachel E. Eisenberg

21 TiP Pivotal Phase 3, Randomized Controlled Trial Evaluating the Safety and Efficacy of Aminolevulinic Acid for the Real-time Visualization of Cancer Through Fluorescent Imaging During Breast-Conserving Surgery

ByEleftherios P. Mamounas, MD, MPH,Rachel E. Eisenberg,Danielle Henry,Michael P. Kahky,Marisa P. Cooke,Jennifer Durant,Michael T. Roberts,Janice M. Porter,Amy Nester,Nayana Thalanki,Kathryn Ottolino-Perry,Ralph. S. DaCosta

April 19th 2022

Latest Updated Articles

Trending on CancerNetwork

FDA Permits Expanded Daraxonrasib Access in Previously Treated Metastatic PDAC

FDA ODAC Votes No to Camizestrant for HR+/HER2– ESR1 Advanced Breast Cancer

FDA Approves Vepdegestrant in ER+, HER2–, ESR1-Mutated Breast Cancer

TIP137 ADELA: A Double-blind, Placebo-Controlled, Randomized Phase 3 Trial of Elacestrant + Everolimus Versus Elacestrant + Placebo in ER+/HER2- Advanced Breast Cancer (aBC) Patients With ESR1-Mutated Tumors Progressing on Endocrine Therapy (ET) + CDK4/6i

138 HER2CLIMB-05: A Randomized, Double-blind, Phase 3 Study of Tucatinib Versus Placebo Added to Trastuzumab and Pertuzumab as Maintenance Therapy for HER2+ Metastatic Breast Cancer